Xenon Pharmaceuticals EPS Diluted from Other Gain/Loss (Quarterly) Analysis

Xenon Pharmaceuticals, Inc. (XENE)

43.52 -1.01 (-2.27%) USD | NASDAQ | Dec 09, 16:00

43.56 +0.04 (+0.09%) After-Hours: 20:00

View EPS Diluted from Other Gain/Loss (Quarterly) for XENE.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View EPS Diluted from Other Gain/Loss (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View EPS Diluted from Other Gain/Loss (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View EPS Diluted from Other Gain/Loss (Quarterly) Benchmarks

Start Trial

Oncolytics Biotech, Inc.	--
Aurinia Pharmaceuticals, Inc.	--
Edesa Biotech, Inc.	--
Lexaria Bioscience Corp.	--
ProMIS Neurosciences, Inc.	--